The Founder's Guide to

Cephalo Ventures

Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.

Explore our founder-friendly guide and choose if you'd like to be connected.
We'll either provide a warm intro or provide you with more suitable alternatives.
Once you're put in touch, we'll provide you with helpful advice. It's 100% free.

Overview

Cephalo Ventures is a venture capital organization founded to support scientific research and innovation. Established in both the United States and the United Kingdom, the firm focuses on investing in scientific advancements that have the potential to positively impact society. The organization primarily targets the fields of therapeutics, synthetic biology, and medical devices.

Currently, Cephalo Ventures manages a portfolio of four notable companies and operates an accelerator program called Transferase Accelerator. This program is designed to assist early-stage biotech startups in their fundraising efforts, providing workshops and access to a network of biotech investors. The firm emphasizes its commitment to funding scientific advancements that yield significant societal benefits.

Learn More

Frequently Asked Questions

What are Cephalo Ventures' investment criteria?

Cephalo Ventures invests in early-stage biotech startups, specifically those in the pre-seed to Series A funding stages. The firm looks for companies that demonstrate potential for significant societal impact, particularly in therapeutics, synthetic biology, and medical devices.

How can I apply or pitch to Cephalo Ventures?

Interested parties can visit the Cephalo Ventures website for applications and pitches. The firm encourages startups to provide detailed information about their business model and potential impact.

What makes Cephalo Ventures different from other investors?

Cephalo Ventures emphasizes funding scientific advancements that yield societal benefits. Their focus on biotech innovation and the support provided through the Transferase Accelerator program distinguishes them in the venture capital landscape.

What is the geographic scope of Cephalo Ventures?

The firm operates in both the United States and the United Kingdom, allowing it to tap into diverse biotech ecosystems and investment opportunities.

What is the typical check size for investments?

Cephalo Ventures typically invests between $150,000 and $300,000 in early-stage biotech startups, providing crucial funding for their development.

What kind of post-investment involvement can startups expect?

While specific details about post-investment involvement are not provided, Cephalo Ventures offers access to a network of biotech investors and resources through their accelerator program, which can support startups in their growth journey.

All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.